Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Operating Leases (2019 - 2025)

Bio Key International (BKYI) has disclosed Operating Leases for 7 consecutive years, with $28967.0 as the latest value for Q3 2025.

  • Quarterly Operating Leases fell 40.99% to $28967.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $28967.0 through Sep 2025, down 40.99% year-over-year, with the annual reading at $48994.0 for FY2024, N/A changed from the prior year.
  • Operating Leases hit $28967.0 in Q3 2025 for Bio Key International, down from $35735.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $211442.0 in Q1 2021 to a low of $9570.0 in Q2 2023.
  • Historically, Operating Leases has averaged $65339.6 across 5 years, with a median of $42410.0 in 2025.
  • Biggest five-year swings in Operating Leases: tumbled 86.45% in 2022 and later tumbled 39.01% in 2023.
  • Year by year, Operating Leases stood at $86974.0 in 2021, then tumbled by 56.51% to $37829.0 in 2022, then crashed by 74.7% to $9570.0 in 2023, then skyrocketed by 411.95% to $48994.0 in 2024, then tumbled by 40.88% to $28967.0 in 2025.
  • Business Quant data shows Operating Leases for BKYI at $28967.0 in Q3 2025, $35735.0 in Q2 2025, and $42410.0 in Q1 2025.